Neurology 2001;56:1666-1672
© 2001 American Academy of Neurology
Articles
Treatment of stroke in rat with intracarotid administration of marrow stromal cells
Y. Li, MD;,
J. Chen, MD;,
L. Wang, MD;,
M. Lu, PhD; and
M. Chopp, PhD
From the Departments of Neurology (Drs. Li, Chen, Wang, and Chopp) and Biostatistics and Research Epidemiology (Dr. Lu), Henry Ford Health Sciences Center, Detroit; and the Department of Physics (Dr. Chopp), Oakland University, Rochester, MI.
Address correspondence and reprint requests to Dr. Michael Chopp, Department of Neurology (E&R3056), Henry Ford Health Sciences Center, 2799 West Grand Boulevard, Detroit, MI 48202; e-mail: chopp{at}neuro.hfh.edu
OBJECTIVE: To measure the therapeutic efficacy for the treatment of stroke with intra-arterial administration of bone marrow stromal cells (MSC).
BACKGROUND: MSC have characteristics of stem and progenitor cells. The hypothesis that MSC injected into the internal carotid artery after stroke enter into ischemic brain and improve neurologic recovery was tested.
METHODS: Twenty-five adult Wistar rats were subjected to transient (2-hour) middle cerebral artery occlusion alone (n = 9), or treated with intracarotid arterial injection of 200 µL phosphate-buffered saline (n = 8) or 2 x 106 MSC in 200 µL phosphate-buffered saline (n = 8) 1 day after ischemia. MSC were harvested and isolated from additional adult rats and then cultured and labeled with bromodeoxyuridine. Rats were subjected to neurologic functional tests (adhesive-removal, modified neurologic severity scores) before and at 1, 7, and 14 days after middle cerebral artery occlusion. Immunohistochemistry was used to identify cell-specific proteins of bromodeoxyuridine-reactive MSC.
RESULTS: Bromodeoxyuridine-reactive cells ( 21% of 2 x 106 injected MSC) distributed throughout the territory of the middle cerebral artery by 14 days after ischemia. Some bromodeoxyuridine-reactive cells expressed proteins characteristic of astrocytes and neurons. Rats with intra-arterial transplantation of MSC exhibited improvement on the adhesive-removal test (p < 0.05) and the modified neurologic severity scores (p < 0.05) at 14 days compared with controls.
CONCLUSIONS: MSC injected intra-arterially are localized and directed to the territory of the middle cerebral artery, and these cells foster functional improvement after cerebral ischemia.
This article has been cited by other articles:

|
 |

|
 |
 
M. K. Reddy and V. Labhasetwar
Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury
FASEB J,
May 1, 2009;
23(5):
1384 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, O. Zis, G. Ma, Z. Shan, X. Zhang, S. Wang, C. Dai, J. Zhao, Q. Lin, S. Lin, et al.
Upregulation of Macrophage Migration Inhibitory Factor Gene Expression in Stroke
Stroke,
March 1, 2009;
40(3):
973 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The STEPS Participants
Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating Stroke
Stroke,
February 1, 2009;
40(2):
510 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr
Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation
Dis. Model. Mech.,
January 1, 2009;
2(1-2):
23 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schwarting, S. Litwak, W. Hao, M. Bahr, J. Weise, and H. Neumann
Hematopoietic Stem Cells Reduce Postischemic Inflammation and Ameliorate Ischemic Brain Injury
Stroke,
October 1, 2008;
39(10):
2867 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Iwanami, M. Mogi, J.-M. Li, K. Tsukuda, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi
Deletion of Angiotensin II Type 2 Receptor Attenuates Protective Effects of Bone Marrow Stromal Cell Treatment on Ischemia-Reperfusion Brain Injury in Mice * Supplemental Materials and Methods
Stroke,
September 1, 2008;
39(9):
2554 - 2559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Walczak, J. Zhang, A. A. Gilad, D. A. Kedziorek, J. Ruiz-Cabello, R. G. Young, M. F. Pittenger, P. C.M. van Zijl, J. Huang, and J. W.M. Bulte
Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia
Stroke,
May 1, 2008;
39(5):
1569 - 1574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Buhnemann, A. Scholz, C. Bernreuther, C. Y. Malik, H. Braun, M. Schachner, K. G. Reymann, and M. Dihne
Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats
Brain,
December 1, 2006;
129(12):
3238 - 3248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, O. Honmou, K. Harada, K. Nakamura, K. Houkin, H. Hamada, and J. D. Kocsis
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia
Brain,
October 1, 2006;
129(10):
2734 - 2745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dalakas, P. N. Newsome, D. J. Harrison, and J. N. Plevris
Hematopoietic stem cell trafficking in liver injury
FASEB J,
August 1, 2005;
19(10):
1225 - 1231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lindvall and Z. Kokaia
Recovery and Rehabilitation in Stroke: Stem Cells
Stroke,
November 1, 2004;
35(11_suppl_1):
2691 - 2694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-W. Jeong, K. Chu, K.-H. Jung, S. U. Kim, M. Kim, and J.-K. Roh
Human Neural Stem Cell Transplantation Promotes Functional Recovery in Rats With Experimental Intracerebral Hemorrhage
Stroke,
September 1, 2003;
34(9):
2258 - 2263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. Suratt, C. D. Cool, A. E. Serls, L. Chen, M. Varella-Garcia, E. J. Shpall, K. K. Brown, and G. S. Worthen
Human Pulmonary Chimerism after Hematopoietic Stem Cell Transplantation
Am. J. Respir. Crit. Care Med.,
August 1, 2003;
168(3):
318 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Howells
Stem Cells: Do They Replace or Stimulate?
Stroke,
August 1, 2003;
34(8):
2082 - 2083.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, Z. G. Zhang, Y. Li, L. Wang, Y. X. Xu, S. C. Gautam, M. Lu, Z. Zhu, and M. Chopp
Intravenous Administration of Human Bone Marrow Stromal Cells Induces Angiogenesis in the Ischemic Boundary Zone After Stroke in Rats
Circ. Res.,
April 4, 2003;
92(6):
692 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun, K. Jin, A. Peel, X. O. Mao, L. Xie, and D. A. Greenberg
Neuroglobin protects the brain from experimental stroke invivo
PNAS,
March 18, 2003;
100(6):
3497 - 3500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Edelberg
Auto Repair on the Aging Stem Cell Superhighway
Sci. Aging Knowl. Environ.,
September 4, 2002;
2002(35):
pe13 - 13.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke,
August 1, 2002;
33(8):
2123 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Korbling, R. L. Katz, A. Khanna, A. C. Ruifrok, G. Rondon, M. Albitar, R. E. Champlin, and Z. Estrov
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells
N. Engl. J. Med.,
March 7, 2002;
346(10):
738 - 746.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|